ANNE WONG: Open Payments
NPI 1861821514 · FISHERSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,195 in 54 payments from 15 companies in 2025. Trend: 2023 $1,147 · 2024 $1,521 · 2025 $1,195
Food & beverage: $1,195
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $275 |
| PFIZER INC. | 9 | $171 |
| UROGEN PHARMA, INC. | 10 | $138 |
| IMMUNITYBIO, INC. | 5 | $104 |
| ABBVIE INC. | 5 | $95 |
| Olympus America Inc. | 1 | $92 |
| Teleflex LLC | 2 | $74 |
| TOLMAR, INC. | 2 | $66 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $54 |
| Merck Sharp & Dohme LLC | 1 | $31 |
Products named: GEMTESA, XTANDI, ANKTIVA, LUPRON DEPOT, UroPass, ORGOVYX, JATENZO, UROLIFT.
Industry payments across VA — which companies pay providers there.
